Citation Impact
Citing Papers
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis
2002
Osteoporosis
2019 Standout
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Biological Designer Self-Assembling Peptide Nanofiber Scaffolds Significantly Enhance Osteoblast Proliferation, Differentiation and 3-D Migration
2007
Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties
1993
Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism
1989
Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
1995
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial)
2003
Hydrogels in Regenerative Medicine
2009 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Hydrogels for tissue engineering: scaffold design variables and applications
2003 Standout
Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering
2006 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study
1994
Use of bisphosphonates in cancer patients
1996
Malignant bone pain: pathophysiology and treatment
1997
A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma
2002
Osteoclast inhibition for the treatment of bone metastases
1993
Treatment of Tumor-Induced Osteolysis by APD
1989
Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients
1994
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Markers of bone resorption in patients treated with pamidronate
1998
Osteoporosis: now and the future
2011 Standout
Bisphosphonates in prostate carcinoma
1997
Recent advances in understanding the mechanism of action of bisphosphonates
2006
ASAS/EULAR recommendations for the management of ankylosing spondylitis
2005
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Discovery of a High Molecular Weight Complex of Calcium, Phosphate, Fetuin, and Matrix γ-Carboxyglutamic Acid Protein in the Serum of Etidronate-treated Rats
2002
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Hypercalcemia Associated with Cancer
2005
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
2007
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Growth Factor Delivery for Bone Tissue Engineering
2001
Ankylosing spondylitis
2007 Standout
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
2011
EAU Guidelines on Prostate Cancer
2007 Standout
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
1998
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Bisphosphonates in cancer therapy
2007
Biomedical applications of collagen
2001 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial
1996
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
2000
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Bisphosphonates: The first 40years
2011
Electrospinning: A fascinating fiber fabrication technique
2010 Standout
Efficacy of Pamidronate in Reducing Skeletal Complications in Patients with Breast Cancer and Lytic Bone Metastases
1996 Standout
Mechanisms of Bone Metastasis
2004 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Three Years Follow-up of Pamidronate Therapy in Two Brothers with Osteoporosis-Pseudoglioma Syndrome (OPPG) Carrying an LRP5 Mutation
2008
Bisphosphonates
1991
The potential role of bisphosphonates in prostate cancer
2002
Biological characterization of EDC-crosslinked collagen–hyaluronic acid matrix in dermal tissue restoration
2003
Effects of the Bisphosphonate Olpadronate in Patients With Carcinoma of the Prostate Metastatic to the Skeleton
1998
Bisphosphonates: A review of their pharmacokinetic properties
1996
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Bisphosphonates: from the laboratory to the clinic and back again
1999
The all-photochemical synthesis of an OGP(10–14) precursor
2011
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
Targeting of Tumor Cells for Human γδ T Cells by Nonpeptide Antigens
2001
Calcium/Vitamin D Supplementation and Cardiovascular Events
2007
The control of the false discovery rate in multiple testing under dependency
2001 Standout
Prevention of Nonvertebral Fractures by Alendronate
1997
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Wavelength-selective cleavage of photoprotecting groups: strategies and applications in dynamic systems
2015 StandoutNobel
Biodegradable polymers as biomaterials
2007 Standout
Bisphosphonates in prostate carcinoma
1997
Long-Term Use of Bisphosphonates in Osteoporosis
2010
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
2000
Tolerability of oral pamidronate in elderly patients with osteoporosis and other metabolic bone diseases
1996
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1996
Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond
2018
Collagen based dressings — a review
2000
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Bisphosphonates Alendronate and Ibandronate Inhibit Artery Calcification at Doses Comparable to Those That Inhibit Bone Resorption
2001
Skeletal complications of malignancy
1997 Standout
Multiple Myeloma
2011 Standout
Oral bisphosphonates
2000
Vascular Calcification
2008 Standout
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Bisphosphonates: Mechanisms of Action
1998
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of S Rosini being referenced
Osteogenic growth peptide effects on primary human osteoblast cultures: Potential relevance for the treatment of glucocorticoid‐induced osteoporosis
2006
Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice
2002
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate
1988
In vitro effects of different formulations of bovine collagen on cultured human skin
1998
The acute-phase response after bisphosphonate administration
1987
Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat
1986
Synthesis of gem-bisphosphonic methotrexate conjugates and their biological response towards Walker's osteosarcoma
1993
Dichloromethylene-Diphosphonate in Patients with Prostatic Carcinoma Metastatic to the Skeleton
1985
Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats
1990
[Treatment of hypercalcemia of myelomatous origin with intravenous diphosphonates].
1983
Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate
1986
Bisphosphonates and atherosclerosis: why?
2005
Potential role of heterologous collagen in promoting cutaneous wound repair in rats.
1992